AI-generated summary
The authors studied photobiomodulation at 780 nm, dexamethasone, and their combination in lipopolysaccharide and interferon-gamma stimulated J774 macrophage cells in vitro. They report that combining photobiomodulation with 2 μM dexamethasone increased metabolic activity at 24 hours and produced the strongest reduction in TNF-α and IL-6. The study was conducted in cultured cells, not people.
- Who or what was studied
- J774 macrophage cell line stimulated with LPS and IFN-γ (in vitro cell culture)
- Wavelengths
- 780 nm
- Limits stated in the abstract
- The study was conducted in cultured macrophage cells rather than in humans or animals, and the abstract does not report a sample size.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The aim of the present study was to investigate the effects of photobiomodulation (PBM), dexamethasone (DEXA), and their combination on cellular metabolic activity and inflammatory cytokines in LPS/IFN-γ-stimulated J774 macrophages. Cells were stimulated with lipopolysaccharide (LPS) and interferon-gamma (IFN-γ) and treated with PBM (780 nm) and/or DEXA (2 or 4 μM). Cellmorphology, metabolic activity assessed by the 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, and total protein, tumornecrosis factor-alpha (TNF-α), and interleukin-6 (IL-6) levels measured by enzyme-linked immunosorbent assay (ELISA) were analyzed at 24 and 48hours. PBM combined with DEXA at 2 μM increased MTT metabolic activity at 24 hours and was associated with preserved morphology and maintainedhigher total protein levels, with consistent superiority over DEXA alone. PBM + DEXA 2 μM produced the strongest reduction in TNF-α and IL-6 at 24hours, and IL-6 levels remained lower at 48 hours compared to the M1 + PBM group. The 4 μM dose demonstrated lower efficacy and signs of functionalimpairment, which were partially mitigated by PBM. These findings indicate that PBM may enhance the anti-inflammatory effects of low-dose DEXA while supporting a favorable cellular metabolic response, suggesting its potential as an adjunct strategy to optimize the glucocorticoid-based modulation ofinflammatory responses.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 780 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.